Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease
Gisa Ellrichmann(Witten/Herdecke University), Ralf A. Linker(University Hospital Regensburg)
Cited by 156
Related Papers
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
|Multiple Sclerosis Journal|2017|142
Inhibition of Huntingtin Exon-1 Aggregation by the Molecular Tweezer CLR01
|Journal of the American Chemical Society|2017|55
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment
|Therapeutic Advances in Neurological Disorders|2015|53